Sabinsa has developed Curcumin C3 Reduct®, the only reductive metabolites of curcuminoids on the market to have been approved as a Novel Food by the European Food Safety Authority (EFSA). Easy to integrate into existing production processes and with the concentrated benefits of curcumin, C3 Reduct® has been shown to boost organ health and deliver a range of other targeted functionalities.
This makes it ideal to help product developers meet consumer health and wellness expectations – and open up new market opportunities.